Xenoport Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Nov 2012 | $20 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Xenoport Inc. had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Nov 2012).
SEC Form D (revenue range) · Nov 2012
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Nov 2012
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Xenoport Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 1 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David R. Savello | Executive officer | Nov 2012 |
| Gianna M. Bosko | Executive officer | Nov 2012 |
| Gregory T. Bates | Executive officer | Nov 2012 |
| Ronald W. Barrett | Executive officer | Nov 2012 |
| Vincent J. Angotti | Executive officer | Nov 2012 |
| William G. Harris | Executive officer | Nov 2012 |
| Catherine J. Friedman | Director | Nov 2012 |
| Dennis M. Fenton | Director | Nov 2012 |
| Ernest L. Mario | Director | Nov 2012 |
| Jeryl L. Hilleman | Director | Nov 2012 |
| John G. Freund | Director | Nov 2012 |
| Paul L. Berns | Director | Nov 2012 |
| Ronald W. Barrett | Director | Nov 2012 |
| Wendell J. Wierenga | Director | Nov 2012 |
| William J. Rieflin | Director | Nov 2012 |